Distinctive Adaptability - AMV Tecnología ca

Distinctive Adaptability
Control when you need it and
protection every step of the way
“Healon5 ® OVD delivers a great combination of
viscomydriasis, procedural control, and endothelial cell
protection in all of my cataract cases, especially IFIS cases.
Regardless of the situation, the versatility of Healon5 ® OVD
fortifies my belief that I am giving my patients the very best.”
— Robert M. Osher, MD
Cincinnati, Ohio

Effectively Adapts to
Your Surgical Needs
• Remarkable dual-property viscoadaptive
-Cohesive properties provide unparalleled space creation
and anterior chamber maintenance
-Dispersive properties allow for outstanding protection
of endothelial cells during phaco
• Designed to maximize control throughout surgery
• Helps provide better-controlled capsulorhexis, 1
phacoemulsification, 1,2 and lens placement 2
• Ideal for floppy iris (IFIS) management
-Mechanically expands the pupil and stabilizes delicate
iris tissue 4,5
-Helps to block the iris from prolapsing to the incisions 5,6
Better Protection
Mean endothelial cell loss
90 days postoperatively
Healon5 ® produced considerably less
mean endothelial cell loss than VisCoat ®
and Ocucoat ® OVDs. 3
Better Control
Healon5 ® OVD
“The ability of Healon5 ® to mechanically expand
the pupil and to block iris prolapse have made it
an excellent choice for IFIS.”
— David F. Chang, MD
Los Altos, CA
VisCoat ® OVD
Healon ® , The Name You Know and Trust
• The standard in reliability
• Known and trusted for 28 years
• Proven worldwide in more than 40 million eyes 4
• Latex free for patient and staff safety
Healon5 ® OVD maintains anterior chamber depth
better than VisCoat ® OVD. 1
®
The Healon Family, your OVD
solution for any situation.
1-877-AMO-4-LIFE
www.Healon.com
1. Holmén JB, Lundgren B. Scheimpflug photography study of ophthalmic viscosurgical devices during simulated cataract surgery. J Cataract Refract Surg. 2003:29:568-574.
2. Tetz MR, Holzer MP, Lundberg K, Auffarth GU, Burk ROW, Kruse FE. Clinical results of phacoemulsification with the use of Healon5 or Viscoat. J Cataract Refract Surg. 2001:27:416-420.
3. Holzer MP, Tetz MR, Auffarth GU, Welt R, Völcker H. Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery. J Cataract Refract Surg. 2001;27:213-218.
4. Data on file. Abbott Medical Optics Inc.
5. Chang DF, Campbell JR. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg. 2005:31:664-73.
6. Chang DF, Braga-Mele R, Mamalis N, et al. ASCRS white paper: clinical review of intraoperative floppy-iris syndrome. J Cataract Refract Surg. 2008:34:2153-62.
Healon ® viscoelastic is used in ophthalmic surgical procedures of the anterior segment, including cataract surgery with an intraocular lens, cataract surgery without an intraocular lens, or secondary intraocular lens implant.
Healon ® , Healon GV ® , and Healon5 ® OVDs are used in ophthalmic surgical procedures to maintain a deep anterior chamber, which facilitates manipulation inside the eye with reduced trauma to the corneal endothelium and other ocular tissues.
Warnings/Precautions/Contraindications: There are no known contraindications to the use of Healon ® , Healon GV ® , and Healon5 ® OVDs when used as recommended. Please refer to package inserts for full prescribing information. Rx only.
AMO, Healon, Healon5, and Healon GV trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. ProVisc and VisCoat are registered trademarks of Alcon
Laboratories, Inc.
©2009 Abbott Medical Optics Inc., Santa Ana, CA 92705 www.AbbottMedicalOptics.com
Reorder: OVD09-04
2009.06.23-CT1113